Cambridge Research LGD-4033 contains 5mg x 60 Capsules. Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.
ChemSpider ID: 29364487
Elimination half-life: 24-36 hours
Other names: VK5211; LGD-4033
PubChem CID: 44137686
What is Cambridge Research LGD-4033?
According to a clinical trial conducted at the Boston Medical Center’s Section of Endocrinology, Ligandrol can help improve lean body mass and muscle strength. Another study conducted in January 2013 found that Ligandrol can help increase lean muscle mass, and was generally well tolerated by test subjects.